Skip to content
Thursday 3 September 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,770.52
+0.13%
DAX
25,825.09
-0.06%
CAC 40
8,254.73
-0.31%
STOXX 50
6,347.66
-0.23%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Wednesday 23 December 2020 2:00 pm  |  Updated:  Wednesday 23 December 2020 2:58 pm

Covid-19: It’s 1-1 at half-time in the biggest match of our lives

By: Alexander von Gabain

Add as a preferred source on Google
Vaccine Rollout Continues In GPs' Surgeries Across The UK
GPs could face being moved around the country under new plans (Photo by Ian Forsyth/Getty Images)

A monumental effort has produced the first vaccines for Covid-19 in a timescale that at the start of the year looked very difficult.

The fact we are now seeing people like Margaret Keenan, the first to receive the vaccine in the UK, given an injection shows the progress made in vaccines over the past 10 years.

Big companies working with small, scientists, charities, sharing information and data for the greater good.

Read more: UK stuck with Tier 4 lockdowns until vaccine rolls out across the country

And it’s that spirit of cooperation that must continue now if we are to truly defeat Covid. Cooperation at a political level on managing this next phase for the benefit of all – and cooperation from the public in taking a vaccine that is so crucial to overcoming the virus.

Do this and we can win.

Because make no mistake, as we’ve seen this week, the match against this deadly virus isn’t over. If it was a football game, we are currently at half-time. It’s 1-1 and as a world we really need to pull together now.

We need to learn which people cope with which vaccine the best, to learn the profile of the vaccines we have developed and the possible side effects they have. 

We need to figure out which vaccines are best at preventing the virus, combating its severity, how long they protect us for and which ones are more suitable for different climates.

We also need to produce enough and work out the best way to distribute the various vaccines so that it’s not only the wealthy part of the world that benefits – but the less wealthy part too.

What concerns me most as a vaccine innovator, a microbiologist is the creeping isolationism and populism among some political leaders, totally misunderstanding the need for teamwork. This idea that we are better than others is outdated and means we fail to master infectious diseases.

You’ve seen this malicious ignorance in the United States under the departing President and, sorry to say, to a degree even in some European countries. 

“We’re better than you.”

“We’re first.”

We seem to be bringing a kind of disruptive contest into this and it could undermine our efforts against Covid.

Read more

ILiAD Biotechnologies Expands Board of Directors and Appoints Chief Business Officer

Read more: R Rate creeps up to 1.4 in the capital

The ‘mutant’ strain recently identified in the UK population, underpins the notion that it’s prudent to move forward a variety of distinct vaccines following the front runners.

We shouldn’t be arrogant. Take the Chinese vaccine. It’s a very well-developed vaccine candidate with a promising profile. It’s based on classical vaccine technology. 

Viruses grown on tissue culture, inactivated, purified and formulated are classical vaccines which are very efficient and proven to be safe – like the one we used against Hepatitis A and Rabies. Classical vaccines which do not need a minus 80 degrees centigrade cold chain for distribution and have a very long shelf life. 

We shouldn’t be arrogant and dismiss it because it’s from China or because it doesn’t use the latest technology.

But critically, as well as political goodwill we also need to educate and make the case for vaccines once more among the public. 

People living in wealthy or even in ‘upcoming’ countries have enjoyed relative freedom from infectious disease for decades, mostly because of vaccines. As a result many of those diseases have nearly disappeared or their spread has at least been kept under control. 

This has led to the gigantic misconception that we don’t need vaccination programmes, but they are essential to protecting society. 

So today, some in better off countries are not willing to recognise that taking vaccines is the only way to get out of this dramatic pandemic crisis. If people want to return to normal life, there really is no other way now than a mass vaccination programme.

While I’m not a friend of authoritarian solutions, we have to be honest and admit we may need to introduce a kind of ‘Immunity Passport’ as an incentive, something that allows those willing to take a vaccine to resume normality while being clear that those who don’t pose a risk.

I wouldn’t necessarily enforce a vaccine, but there are many sectors in our economic life, in our social life, where if somebody refuses to be vaccinated, she or he has to accept that this will exclude them from some type of standard, economical and social activity.

As I mentioned. We are only at half-time. We are facing a team of 11 very strong, little red viruses. We have to put all our nerve, strength – and teamwork – into the second half.

If we do we will return to the normal life we crave.

Read more: Wanted: A Minister for Hospitality

Read more

UK debt ‘hits £3 trillion’ milestone

Houses of Parliament in Westminster showcasing historic architecture under a clear sky, central to UK government and politics

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • Opinion

Categories

  • Opinion

Related Topics

  • Coronavirus

Trending Articles

  • Vodafone and Deliveroo look to patch up Reform ties after Yusuf prison threats

  • Trio of firms poised to quit London Stock Exchange as exodus gathers pace

  • Jim O’Neill: Capital gains tax hike ‘looms’ as top option for Burnham

  • Easyjet’s over-60s recruitment push is economically necessary

  • ‘Large tax hikes on the way’: How the global bond rout is boxing in Healey

More from Morning Wire

  • ILiAD Biotechnologies Expands Board of Directors and Appoints Chief Business Officer

    Business Wire
  • UK debt ‘hits £3 trillion’ milestone

    Economics
    Houses of Parliament in Westminster showcasing historic architecture under a clear sky, central to UK government and politics
  • IMF sounds alarm on borrowing costs surge as bond rout deepens

    Economics
    Chancellor John Healey smiling, wearing a navy suit, white shirt, and red tie.
  • ‘Alice in Wonderland’ workspace firm lands £129m Aberdeen-backed finance

    Property
    Modern reception area with unique legs art installation, white desk, and colorful stools.
  • City firms face FCA clampdown on bullying and harassment

    Legal
    The FCA said in June any scheme must keep the market afloat in order to curb rising costs for consumers.
  • International Swimming League set to make comeback in London this year

    Sport Business
    Swimmers diving from starting blocks into a pool during an ISL match at London Aquatics Centre, Nov 2019.
  • Ari Emmanuel snaps up West End theatre group ATG for £4.5bn

    Hospitality
    Paddington Bear in a blue duffle coat and red hat on a purple background with BAFTA and EE logos
  • Jobs market ‘stops moving’ as employment costs weigh on hirers

    Economics
    The recruitment industry is grappling with a slowdown in hiring among UK employers and wider macro-economic uncertainty.
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook